153 related articles for article (PubMed ID: 38639882)
21. Clinical significance of conformity index and gradient index in patients undergoing stereotactic radiosurgery for a single metastatic tumor.
Aiyama H; Yamamoto M; Kawabe T; Watanabe S; Koiso T; Sato Y; Higuchi Y; Ishikawa E; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2018 Dec; 129(Suppl1):103-110. PubMed ID: 30544326
[TBL] [Abstract][Full Text] [Related]
22. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC).
Minniti G; Scaringi C; Lanzetta G; Anzellini D; Bianciardi F; Tolu B; Morace R; Romano A; Osti M; Gentile P; Paolini S
Lung Cancer; 2019 Jun; 132():119-125. PubMed ID: 31097084
[TBL] [Abstract][Full Text] [Related]
23. A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer.
Lim SH; Lee JY; Lee MY; Kim HS; Lee J; Sun JM; Ahn JS; Um SW; Kim H; Kim BS; Kim ST; Na DL; Sun JY; Jung SH; Park K; Kwon OJ; Lee JI; Ahn MJ
Ann Oncol; 2015 Apr; 26(4):762-768. PubMed ID: 25538174
[TBL] [Abstract][Full Text] [Related]
24. Predictors of Survival After Stereotactic Radiosurgery for Untreated Single Non-Small Cell Lung Cancer Brain Metastases: 5- and 10-year Results.
Becco Neto E; Chaves de Almeida Bastos D; Telles JPM; Figueiredo EG; Teixeira MJ; de Assis de Souza Filho F; Prabhu S
World Neurosurg; 2023 Apr; 172():e447-e452. PubMed ID: 36682534
[TBL] [Abstract][Full Text] [Related]
25. Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients.
Yomo S; Hayashi M
BMC Cancer; 2015 Mar; 15():95. PubMed ID: 25879433
[TBL] [Abstract][Full Text] [Related]
26. Early posttreatment assessment of MRI perfusion biomarkers can predict long-term response of lung cancer brain metastases to stereotactic radiosurgery.
Taunk NK; Oh JH; Shukla-Dave A; Beal K; Vachha B; Holodny A; Hatzoglou V
Neuro Oncol; 2018 Mar; 20(4):567-575. PubMed ID: 29016814
[TBL] [Abstract][Full Text] [Related]
27. Impact of time of day on outcomes after stereotactic radiosurgery for non-small cell lung cancer brain metastases.
Badiyan SN; Ferraro DJ; Yaddanapudi S; Drzymala RE; Lee AY; Silver SA; Dyk P; DeWees T; Simpson JR; Rich KM; Robinson CG
Cancer; 2013 Oct; 119(19):3563-9. PubMed ID: 23839874
[TBL] [Abstract][Full Text] [Related]
28. Risk Factors for Progression and Toxic Effects After Preoperative Stereotactic Radiosurgery for Patients With Resected Brain Metastases.
Prabhu RS; Akinyelu T; Vaslow ZK; Matsui JK; Haghighi N; Dan T; Mishra MV; Murphy ES; Boyles S; Perlow HK; Palmer JD; Udovicich C; Patel TR; Wardak Z; Woodworth GF; Ksendzovsky A; Yang K; Chao ST; Asher AL; Burri SH
JAMA Oncol; 2023 Aug; 9(8):1066-1073. PubMed ID: 37289451
[TBL] [Abstract][Full Text] [Related]
29. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.
Kirkpatrick JP; Wang Z; Sampson JH; McSherry F; Herndon JE; Allen KJ; Duffy E; Hoang JK; Chang Z; Yoo DS; Kelsey CR; Yin FF
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):100-8. PubMed ID: 25442342
[TBL] [Abstract][Full Text] [Related]
30. Relevance of gamma knife radiosurgery alone for the treatment of non-small cell lung cancer brain metastases.
Zairi F; Ouammou Y; Le Rhun E; Aboukais R; Blond S; Vermandel M; Deken V; Devos P; Reyns N
Clin Neurol Neurosurg; 2014 Oct; 125():87-93. PubMed ID: 25108698
[TBL] [Abstract][Full Text] [Related]
31. A volume matched comparison of survival after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases.
Wei Z; Niranjan A; Abou-Al-Shaar H; Deng H; Albano L; Lunsford LD
J Neurooncol; 2022 May; 157(3):417-423. PubMed ID: 35316437
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
[TBL] [Abstract][Full Text] [Related]
33. Gamma knife stereotactic radiosurgery for the management of incidentally-identified brain metastasis from non-small cell lung cancer.
Marko NF; Suh JH; Chao ST; Barnett GH; Vogelbaum MA; Toms S; Weil RJ; Angelov L
J Neurooncol; 2011 Sep; 104(3):817-24. PubMed ID: 21431468
[TBL] [Abstract][Full Text] [Related]
34. Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients.
Lehrer EJ; Ahluwalia MS; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Jones BM; Green S; Sheehan JP; Trifiletti DM
J Neurosurg; 2023 May; 138(5):1178-1187. PubMed ID: 36115055
[TBL] [Abstract][Full Text] [Related]
35. Comparison of preoperative versus postoperative treatment dosimetry plans of single-fraction stereotactic radiosurgery for surgically resected brain metastases.
Cheok SK; Yu C; Feng JJ; Briggs RG; Chow F; Hwang L; Ye JC; Attenello FJ; Tran D; Chang E; Zada G
Neurosurg Focus; 2023 Aug; 55(2):E9. PubMed ID: 37527673
[TBL] [Abstract][Full Text] [Related]
36. Single-Fraction Versus Fractionated Preoperative Radiosurgery for Resected Brain Metastases: A PROPS-BM International Multicenter Cohort Study.
Prabhu RS; Akinyelu T; Vaslow ZK; Matsui JK; Haghighi N; Dan T; Mishra MV; Murphy ES; Boyles S; Perlow HK; Palmer JD; Udovicich C; Patel TR; Wardak Z; Woodworth GF; Ksendzovsky A; Yang K; Chao ST; Asher AL; Burri SH
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):650-661. PubMed ID: 37717787
[TBL] [Abstract][Full Text] [Related]
37. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
38. The impact of EGFR-TKI use on clinical outcomes of lung adenocarcinoma patients with brain metastases after Gamma Knife radiosurgery: a propensity score-matched analysis based on extended JLGK0901 dataset (JLGK0901-EGFR-TKI).
Yomo S; Serizawa T; Yamamoto M; Higuchi Y; Sato Y; Shuto T; Akabane A; Jokura H; Kawagishi J; Aoyama H
J Neurooncol; 2019 Oct; 145(1):151-157. PubMed ID: 31487030
[TBL] [Abstract][Full Text] [Related]
39. Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases.
Iorio-Morin C; Mercure-Cyr R; Figueiredo G; Touchette CJ; Masson-Côté L; Mathieu D
J Neurooncol; 2019 Dec; 145(3):551-559. PubMed ID: 31667732
[TBL] [Abstract][Full Text] [Related]
40. Impacts of EGFR-mutation status and EGFR-TKI on the efficacy of stereotactic radiosurgery for brain metastases from non-small cell lung adenocarcinoma: A retrospective analysis of 133 consecutive patients.
Yomo S; Oda K
Lung Cancer; 2018 May; 119():120-126. PubMed ID: 29656746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
